LOXL2 and chronic obstructive pulmonary disease: The inhibition of oxidases such as semicarbazide-sensitive amineoxidase (SSAO) and lysyl oxidase like 2(LOXL2) has been put forward as important for reducing COPD symptoms [79,80].